Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer (Q34617956)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer
scientific article

    Statements

    Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer. (English)
    Matthew R Smith
    Ronald A Morton
    K Gary Barnette
    Paul R Sieber
    S Bruce Malkowicz
    Domingo Rodriguez
    Michael L Hancock
    Mitchell S Steiner
    17 August 2010
    1316-1321

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit